Not Enough Evidence Exists to Support Cannabis for Parkinson Disease
Consensus statement calls for more rigorous research to assess clinical benefit
Intracerebral Hemorrhage Incidence Rate Stabilizing
Continued increase in incidence for those ≥75 years coincides with increase in use of anticoagulant meds
Antiepileptic Drugs May Up Death Risk in Patients With Alzheimer Disease
Mortality risk highest during the first three months of treatment with antiepileptic drugs
Young With Intellectual Disability More Likely to Die of COVID-19
Concentration of COVID-19 cases, case fatality in those with IDD higher at younger ages
Delay in Treatment Seen for Acute Ischemic Stroke During COVID-19
Mean interval from last-known-well time to presentation significantly longer in March 2020
ABCDE Bundle Can Reduce Ventilation Time for ICU Patients
Awakening and breathing coordination, delirium monitoring/management, early mobility are key
May 2020 Briefing – Neurology
Here are what the editors at HealthDay consider to be the most important developments in Neurology for May 2020. This roundup includes the latest...
Multiple Sclerosis Tied to Higher Risk for CVD, Cerebrovascular Disease
MS associated with a 3.5-fold higher risk for mortality, 1.5-fold higher risk for cardiovascular mortality
Exposure to Urban Air Pollution May Up Risk of Multiple Sclerosis
Adjusted risk 29 percent higher among those residing in more urbanized areas
Spirituality May Have Protective Effect on QOL for Stroke Survivors
Spirituality may moderate link between care partner depressive symptoms and survivor psychological QOL
